Compare Globalstar (GSAT) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globalstar vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Globalstar trades at $82.76 (market cap $10.78B), while Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B). The key difference: Globalstar is far larger — about 6.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Globalstar is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 20 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| GSAT | NUVB | |
|---|---|---|
Market Cap | $10.78B | $1.74B |
Volume | 723,953 | 9,289,619 |
Sector | Media | Health |
52-Week High | $84.43 | $9.54 |
52-Week Low | $41.54 | $3.41 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $10.79B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
